DIAGNOS Statistics

Total Valuation

DIAGNOS has a market cap or net worth of CAD 36.12 million. The enterprise value is 34.61 million.

Market Cap	36.12M
Enterprise Value	34.61M

Important Dates

The last earnings date was Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

DIAGNOS has 120.41 million shares outstanding. The number of shares has increased by 28.02% in one year.

Current Share Class	120.41M
Shares Outstanding	120.41M
Shares Change (YoY)	+28.02%
Shares Change (QoQ)	+14.81%
Owned by Insiders (%)	4.42%
Owned by Institutions (%)	n/a
Float	115.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	529.99
PB Ratio	24.15
P/TBV Ratio	24.15
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.35
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.05

Financial Position

The company has a current ratio of 1.75, with a Debt / Equity ratio of 1.26.

Current Ratio	1.75
Quick Ratio	1.68
Debt / Equity	1.26
Debt / EBITDA	n/a
Debt / FCF	-0.49
Interest Coverage	-9.34

Financial Efficiency

Return on equity (ROE) is -924.30% and return on invested capital (ROIC) is -89.20%.

Return on Equity (ROE)	-924.30%
Return on Assets (ROA)	-77.80%
Return on Invested Capital (ROIC)	-89.20%
Return on Capital Employed (ROCE)	-246.35%
Weighted Average Cost of Capital (WACC)	4.02%
Revenue Per Employee	3,098
Profits Per Employee	-213,998
Employee Count	22
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.29% in the last 52 weeks. The beta is -0.19, so DIAGNOS's price volatility has been lower than the market average.

Beta (5Y)	-0.19
52-Week Price Change	-14.29%
50-Day Moving Average	0.32
200-Day Moving Average	0.28
Relative Strength Index (RSI)	50.30
Average Volume (20 Days)	169,022

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DIAGNOS had revenue of CAD 68,159 and -4.71 million in losses. Loss per share was -0.05.

Revenue	68,159
Gross Profit	-1.43M
Operating Income	-4.42M
Pretax Income	-4.71M
Net Income	-4.71M
EBITDA	-4.40M
EBIT	-4.42M
Loss Per Share	-0.05

Full Income Statement

Balance Sheet

The company has 3.40 million in cash and 1.89 million in debt, with a net cash position of 1.51 million or 0.01 per share.

Cash & Cash Equivalents	3.40M
Total Debt	1.89M
Net Cash	1.51M
Net Cash Per Share	0.01
Equity (Book Value)	1.50M
Book Value Per Share	0.01
Working Capital	1.58M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.81 million and capital expenditures -10,792, giving a free cash flow of -3.82 million.

Operating Cash Flow	-3.81M
Capital Expenditures	-10,792
Free Cash Flow	-3.82M
FCF Per Share	-0.03

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-6,483.54%
Pretax Margin	-6,907.32%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DIAGNOS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-28.02%
Shareholder Yield	-28.02%
Earnings Yield	-13.03%
FCF Yield	-10.59%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 24, 2019. It was a reverse split with a ratio of 0.1.

Last Split Date	Apr 24, 2019
Split Type	Reverse
Split Ratio	0.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	3